We are excited to announce our Regulation D (REG D 506 (C)) offering – A defining moment in our ceaseless pursuit of innovation in diagnostics and healthcare solutions.We invite the investors to join us as we execute on market expansion and fast-track the development of next-generation, high-impact solutions.
We are welcoming investors around the world and accepting accredited investors from USA.
If you are an investor interested in participating in this offering, please follow the registration by clicking on the “I want to invest” link or contact our investor relations team to receive the Private Placement Memorandum (PPM), subscription documents, and other relevant materials. Also Read the guidelines below.
investment@csdcorp.us
+971 52 8611930
Mohammad EsSayed
+49 162 2415292
Thomas Fahrhoefer
Thank you for your interest in the CS Diagnostics Corp. Regulation D, Rule 506(c) Offering. Please review the steps below before proceeding
Review Terms & Conditions
Read and acknowledge the Terms & Conditions.
Complete and submit the investor form with your details and intended investment amount.
Provide Investor Information
Sign Subscription Agreement
You will receive the Subscription Agreement to review and sign. Submit the signed agreement along with the required documentation.
Our team will review your submission. Upon approval, we will countersign the agreement and provide a secure payment link.
Company Review & Approval
Fund & Confirm
Complete the payment. Once accepted, you will receive confirmation of your investment and a fully executed agreement and Certification
Advancement of our diagnostic technologies including CS-Protect Hydrogel, the pinnacle of innovation in prostate cancer care.
Scaling manufacturing and distribution of MEDUSA, a fast-acting surface disinfectant that protects against a wide range of pathogens.
We foster strategic partnerships and collaborations that drive innovation, expand market reach, and unlock mutual value.
Enhancing regulatory approvals and market readiness for global product launches
Expansion into U.S. and international markets
Strengthen R&D and operational efficiency
CSDX’s website and its contents are provided for informational purposes only and do not constitute an offer to sell or a solicitation of an offer to buy any securities. Any securities offered by the Company will be made only pursuant to definitive offering documents, and only in compliance with Regulation D, Rule 506(c), of the Securities Act of 1933, as amended, and applicable state securities laws. Access to any potential investment opportunity will be limited to persons who have been verified as accredited investors, as defined under Rule 501(a) of Regulation D.
Following are the key benefits for our investors who are ready to invest
SEC-compliant private offering under REG D
Our offering includes a possibility to secure your investment with 3% of your invested money via SinoSecure
We update our investors on a regular basis about all upcoming steps behind the scenes.
Take the first step toward your investment opportunity.
Fill in your details and start building your portfolio with us.
1) Review Terms & Conditions
Read and acknowledge the Terms & Conditions.
2)Provide Investor Information
Complete and submit the investor form with your details and intended investment amount.
3)Sign Subscription Agreement
You will receive the Subscription Agreement to review and sign. Submit the signed agreement along with the required documentation.
4)Company Review & Approval
Our team will review your submission. Upon approval, we will countersign the agreement and provide a secure payment link.
5)Fund & Confirm
Complete the payment. Once accepted, you will receive confirmation of your investment and a fully executed agreement and certifications.
